These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15954518)

  • 1. Sweet syndrome associated with furosemide.
    Govindarajan G; Bashir Q; Kuppuswamy S; Brooks C
    South Med J; 2005 May; 98(5):570-2. PubMed ID: 15954518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole-induced Sweet syndrome: a new association.
    Baquerizo Nole KL; Lee E; Villada G; Romanelli P
    Am J Dermatopathol; 2015 May; 37(5):419-22. PubMed ID: 25590289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic lichenoid eruption due to furosemide.
    Arias-Santiago S; Aneiros-Fernandez J; Aceituno-Madera P; Burkhardt-Perez P; Naranjo Sintes R
    Acta Derm Venereol; 2010; 90(1):78-9. PubMed ID: 20107731
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe Sweet's Syndrome with Elevated Cutaneous Interleukin-1β after Azathioprine Exposure: Case Report and Review of the Literature.
    Imhof L; Meier B; Frei P; Kamarachev J; Rogler G; Kolios A; Navarini AA; Contassot E; French LE
    Dermatology; 2015; 230(4):293-8. PubMed ID: 25791317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib-induced Sweet's syndrome.
    Fye KH; Crowley E; Berger TG; LeBoit PE; Connolly MK
    J Am Acad Dermatol; 2001 Aug; 45(2):300-2. PubMed ID: 11464196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furosemide-induced eruption of haemorrhagic bullae on the fingers.
    Sladden D; Mizzi S; Casha AR; Manché A
    Br J Hosp Med (Lond); 2016 Jul; 77(7):428-9. PubMed ID: 27388387
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitrofurantoin-associated Sweet's syndrome.
    Retief CR; Malkinson FD
    Cutis; 1999 Mar; 63(3):177-9. PubMed ID: 10190073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.
    Zenuk C; Healey J; Donnelly J; Vaillancourt R; Almalki Y; Smith S
    Can J Clin Pharmacol; 2003; 10(4):184-8. PubMed ID: 14712323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delayed allergic reaction to furosemide with a positive lymphocyte transformation test].
    Monge-Ortega OP; Domínguez-Ortega J; González-Muñoz M; Cabañas R; Lluch-Bernal MM; Fiandor A; Bravo-Gallego LY; Quirce S
    Rev Alerg Mex; 2019; 66(2):254-256. PubMed ID: 31200423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furosemide-induced eruption simulating Sweet's syndrome.
    Cobb MW
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):339-43. PubMed ID: 2526826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperacute leucopenia associated with furosemide.
    Ma BJ
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29167185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bortezomib-induced eruption: Sweet syndrome? Two case reports].
    Thuillier D; Lenglet A; Chaby G; Royer R; Vaida I; Viseux V; Dadban A; Billet A; Christophe O; Chatelain D; Marolleau JP; Lok C; Damaj G
    Ann Dermatol Venereol; 2009 May; 136(5):427-30. PubMed ID: 19442799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous Sweet's syndrome and pseudolymphoma precipitated by IL-2 therapy.
    Rondina A; Watson AC
    Cutis; 2010 Apr; 85(4):206-13. PubMed ID: 20486462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sweet's syndrome and phenylbutazone-induced sialadenitis].
    Levang J; Muller P; Girardin P; Humbert P
    Ann Dermatol Venereol; 2008 Apr; 135(4):291-4. PubMed ID: 18420076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib-induced histiocytoid Sweet syndrome.
    Murase JE; Wu JJ; Theate I; Cole GW; Barr RJ; Dyson SW
    J Am Acad Dermatol; 2009 Mar; 60(3):496-7. PubMed ID: 19231647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute generalized exanthematous pustulosis (AGEP) following intake of furosemide].
    Davidovici BB; Naveh HP; Cagnano E; Halevy S;
    Harefuah; 2006 Jul; 145(7):477-9, 552. PubMed ID: 16900732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of Sweet's syndrome during all-trans retinoic acid therapy for acute promyelocytic leukemia].
    Ueno R; Takeuchi J; Shimizu T; Kumagai T; Sawada U; Horie T
    Rinsho Ketsueki; 2000 Sep; 41(9):718-22. PubMed ID: 11070932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.